Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
34 studies found for:    " August 13, 2008":" September 12, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" August 13, 2008":" September 12, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Affect Management Intervention for Early Adolescents Wtih Mental Health Problems
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: General Health Promotion
2 Unknown  Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects
Condition: HIV Infections
Intervention: Drug: Raltegravir and Abacavir/Lamivudine
3 Completed An Affect Management Intervention for Juvenile Offenders
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: General Health Promotion
4 Completed IMARA, Adapting SiHLE for Detained African American Adolescent Females
Condition: HIV Infections
Intervention: Behavioral: IMARA HIV Prevention Intervention
5 Completed
Has Results
Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women
Condition: HIV Infections
Intervention: Drug: Raltegravir
6 Completed Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients
Condition: HIV Infections
Intervention: Drug: lopinavir/ritonavir and raltegravir
7 Completed Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine
Condition: HIV Infections
Intervention: Biological: Tat protein
8 Completed Effect of an Online Video-Based Intervention to Increase HIV Testing in Men Who Have Sex With Men in Peru
Condition: HIV Infections
Interventions: Device: HIV-testing motivational videos;   Device: Standard public health text
9 Completed
Has Results
BRAVO: Background Regimen of Raltegravir on Virologic Outcome
Condition: HIV Infections
Intervention: Drug: raltegravir
10 Completed Surveillance and Medical Help for HIV-infected Intravenous Drug Users in and Out of Prison
Condition: HIV Infections
Intervention:
11 Unknown  Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment
Condition: HIV Infections
Intervention: Drug: Raltegravir and Atazanavir
12 Completed Assessment of Cytokine Values in Serum and by RT-PCR in HIV-1 Individuals With and Without HAART
Condition: HIV Infections
Intervention:
13 Completed
Has Results
Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS
Conditions: HIV Infections;   Fatigue
Interventions: Drug: Armodafinil;   Drug: Placebo
14 Terminated
Has Results
A Study to Determine the Safety and Efficacy of Once Daily Raltegravir Compared to Twice Daily Raltegravir (MK-0518-071)
Condition: HIV
Interventions: Drug: Comparator: Raltegravir 400 mg b.i.d.;   Drug: Experimental: Raltegravir 800 mg q.d.;   Drug: TRUVADA™
15 Completed Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744 10 mg oral solution;   Drug: GSK1265744 5 mg tablet
16 Completed
Has Results
Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing.
Conditions: HIV Infections;   HSV-2 Genital Herpes
Intervention: Drug: 3% SPL7013 Gel (VivaGel)
17 Terminated A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
Conditions: HIV;   Tuberculosis
Interventions: Drug: lopinavir/ritonavir;   Drug: rifabutin
18 Completed TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State.
Condition: HIV
Intervention: Drug: TMC278
19 Completed Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen
Condition: HIV
Intervention: Drug: Raltegravir
20 Completed Attitudes and Beliefs and the Steps of HIV Care
Condition: Human Immunodeficiency Virus Infections
Intervention: Behavioral: Questionnaire

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.